tiprankstipranks
10x Genomics Inc (TXG)
NASDAQ:TXG

10x Genomics (TXG) Financial Statements

710 Followers

10x Genomics Financial Overview

10x Genomics's market cap is currently ―. The company's EPS TTM is $-2.176; its P/E ratio is -16.69; 10x Genomics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 183.98M$ 153.64M$ 146.82M$ 134.28M$ 156.23M
Gross Profit$ 115.78M$ 95.53M$ 146.82M$ 98.39M$ 119.41M
EBIT$ -46.59M$ -91.74M$ -60.76M$ -49.63M$ -19.10M
EBITDA$ -34.88M$ -80.32M$ -48.88M$ -41.02M$ -10.42M
Net Income Common Stockholders$ -131.76M$ -10.18M$ -62.41M$ -50.75M$ -17.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 388.69M$ 356.91M$ 392.88M$ 420.79M$ 432.58M
Total Assets$ 965.14M$ 948.54M$ 989.64M$ 1.01B$ 1.03B
Total Debt$ 95.37M$ 98.47M$ 99.62M$ 102.04M$ 95.18M
Net Debt$ -293.32M$ -258.43M$ -293.27M$ -318.75M$ -337.41M
Total Liabilities$ 224.10M$ 203.32M$ 196.34M$ 211.65M$ 1.03B
Stockholders Equity$ 741.04M$ 745.22M$ 793.30M$ 802.38M$ 805.74M
Cash Flow-
Free Cash Flow$ 22.31M$ -40.76M$ -36.87M$ -9.41M$ -26.01M
Operating Cash Flow$ 25.76M$ -25.32M$ -11.51M$ -4.13M$ 13.72M
Investing Cash Flow$ 13.10M$ 4.90M$ -4.46M$ 119.96M$ -33.17M
Financing Cash Flow$ 5.61M$ 4.37M$ 7.10M$ -3.41M$ 5.00M
Currency in USD

10x Genomics Earnings and Revenue History

10x Genomics Debt to Assets

10x Genomics Cash Flow

10x Genomics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis